Variations of the lung microbiome and immune response in mechanically ventilated surgical patients

Ryan M Huebinger, Ashley D Smith, Yan Zhang, Nancy L Monson, Sara J Ireland, Robert C Barber, John C Kubasiak, Christian T Minshall, Joseph P Minei, Steven E Wolf, Michael S Allen, Ryan M Huebinger, Ashley D Smith, Yan Zhang, Nancy L Monson, Sara J Ireland, Robert C Barber, John C Kubasiak, Christian T Minshall, Joseph P Minei, Steven E Wolf, Michael S Allen

Abstract

Mechanically ventilated surgical patients have a variety of bacterial flora that are often undetectable by traditional culture methods. The source of infection in many of these patients remains unclear. To address this clinical problem, the microbiome profile and host inflammatory response in bronchoalveolar lavage samples from the surgical intensive care unit were examined relative to clinical pathology diagnoses. The hypothesis was tested that clinical diagnosis of respiratory tract flora were similar to culture positive lavage samples in both microbiome and inflammatory profile. Bronchoalveolar lavage samples were collected in the surgical intensive care unit as standard of care for intubated individuals with a clinical pulmonary infection score of >6 or who were expected to be intubated for >48 hours. Cytokine analysis was conducted with the Bioplex Pro Human Th17 cytokine panel. The microbiome of the samples was sequenced for the 16S rRNA region using the Ion Torrent. Microbiome diversity analysis showed the culture-positive samples had the lowest levels of diversity and culture negative with the highest based upon the Shannon-Wiener index (culture positive: 0.77 ± 0.36, respiratory tract flora: 2.06 ± 0.73, culture negative: 3.97 ± 0.65). Culture-negative samples were not dominated by a single bacterial genera. Lavages classified as respiratory tract flora were more similar to the culture-positive in the microbiome profile. A comparison of cytokine expression between groups showed increased levels of cytokines (IFN-g, IL-17F, IL-1B, IL-31, TNF-a) in culture-positive and respiratory tract flora groups. Culture-positive samples exhibited a more robust immune response and reduced diversity of bacterial genera. Lower cytokine levels in culture-negative samples, despite a greater number of bacterial species, suggest a resident nonpathogenic bacterial community may be indicative of a normal pulmonary environment. Respiratory tract flora samples were most similar to the culture-positive samples and may warrant classification as culture-positive when considering clinical treatment.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Flowchart of bronchoalveolar lavage samples…
Fig 1. Flowchart of bronchoalveolar lavage samples collected from the surgical intensive care unit.
Fig 2. Relative abundance of bacterial genera…
Fig 2. Relative abundance of bacterial genera in culture-negative, culture-positive, and RTF (respiratory tract flora) for bronchoalveolar lavage (BAL) samples.
Genus-level taxonomic designations with 2% relative abundance are presented.
Fig 3. Principal coordinate analysis (PCoA) for…
Fig 3. Principal coordinate analysis (PCoA) for bronchoalveolar lavage samples based on unweighted (A) and weighted (B) UniFrac distances.
Culture-negative samples (C-) are shaded in blue, culture-positive (C+) in red, and respiratory tract flora (RTF) samples in green.
Fig 4. T-distributed stochastic neighbor embedding (tSNE)…
Fig 4. T-distributed stochastic neighbor embedding (tSNE) plot of cytokine profiles from bronchoalveolar lavage samples.
Culture-negative (C-) samples are shaded in blue, culture-positive (C+) in red, and respiratory tract flora (RTF) samples in green.
Fig 5. Statistical analysis of 16S rRNA…
Fig 5. Statistical analysis of 16S rRNA gene copy numbers in culture-negative, culture-positive, and respiratory tract flora (RTF) for bronchoalveolar lavage (BAL) samples.
In all, 16S rRNA gene copy numbers from culture-negative, culture-positive, and RTF BAL samples were quantified using droplet digital PCR. Includes values from Table 2 that were compared using a Kruskal-Wallis test in GraphPad Prism 7 (p = 0.0057). Dunn’s post-hoc multiple comparison test was utilized to adjust P-values to determine statistical significance at *P < 0.05. Culture negative 16s copy numbers were statistically significant between culture positive (adjusted P = 0.0154) and respiratory tract flora samples (adjusted P = 0.0442). 16s copy numbers were not statistically significant between respiratory tract flora and culture positive samples (adjusted P>0.999). Error bars are represented as median and inter-quartile range.

References

    1. Kitsios GD, Morowitz MJ, Dickson RP, Huffnagle GB, McVerry BJ, Morris A. Dysbiosis in the intensive care unit: Microbiome science coming to the bedside. J Crit Care. 2017;38:84–91. 10.1016/j.jcrc.2016.09.029
    1. Yeh A, Rogers MB, Firek B, Neal MD, Zuckerbraun BS, Morowitz MJ. Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients. Shock. 2016;46(6):649–54. 10.1097/SHK.0000000000000691 .
    1. Hoggard M, Biswas K, Zoing M, Wagner Mackenzie B, Taylor MW, Douglas RG. Evidence of microbiota dysbiosis in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016. 10.1002/alr.21871 .
    1. Zhang Q, Cox M, Liang Z, Brinkmann F, Cardenas PA, Duff R, et al. Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes. PLoS One. 2016;11(4):e0152724 10.1371/journal.pone.0152724
    1. Einarsson GG, Comer DM, McIlreavey L, Parkhill J, Ennis M, Tunney MM, et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016;71(9):795–803. 10.1136/thoraxjnl-2015-207235 .
    1. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011;6(2):e16384.
    1. de Steenhuijsen Piters WA, Huijskens EG, Wyllie AL, Biesbroek G, van den Bergh MR, Veenhoven RH, et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J. 2016;10(1):97–108. 10.1038/ismej.2015.99
    1. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. 10.1093/cid/ciw353
    1. Leonard KL, Borst GM, Davies SW, Coogan M, Waibel BH, Poulin NR, et al. Ventilator-Associated Pneumonia in Trauma Patients: Different Criteria, Different Rates. Surg Infect (Larchmt). 2016;17(3):363–8. 10.1089/sur.2014.076 .
    1. Piriyapatsom A, Lin H, Pirrone M, De Pascale G, Corona De Lapuerta J, Bittner EA, et al. Evaluation of the Infection-Related Ventilator-Associated Events Algorithm for Ventilator-Associated Pneumonia Surveillance in a Trauma Population. Respir Care. 2016;61(3):269–76. 10.4187/respcare.04280 .
    1. Michetti CP, Fakhry SM, Ferguson PL, Cook A, Moore FO, Gross R, et al. Ventilator-associated pneumonia rates at major trauma centers compared with a national benchmark: a multi-institutional study of the AAST. J Trauma Acute Care Surg. 2012;72(5):1165–73.
    1. Croce MA, Swanson JM, Magnotti LJ, Claridge JA, Weinberg JA, Wood GC, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma. 2006;60(3):523–7; discussion 7–8. 10.1097/01.ta.0000204033.78125.1b .
    1. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, Rozenberg-Arska M, Joore HC, Buskens E, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004;30(2):217–24. 10.1007/s00134-003-2018-2 .
    1. Baselski V, Klutts JS, Baselski V, Klutts JS. Quantitative cultures of bronchoscopically obtained specimens should be performed for optimal management of ventilator-associated pneumonia. J Clin Microbiol. 2013;51(3):740–4. 10.1128/JCM.03383-12
    1. Zakharkina T, Martin-Loeches I, Matamoros S, Povoa P, Torres A, Kastelijn JB, et al. The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia. Thorax. 2017;72(9):803–10. 10.1136/thoraxjnl-2016-209158 .
    1. Conway Morris A, Gadsby N, McKenna JP, Hellyer TP, Dark P, Singh S, et al. 16S pan-bacterial PCR can accurately identify patients with ventilator-associated pneumonia. Thorax. 2017;72(11):1046–8. 10.1136/thoraxjnl-2016-209065
    1. May AK, Brady JS, Romano-Keeler J, Drake WP, Norris PR, Jenkins JM, et al. A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia. Chest. 2015;147(6):1494–502. 10.1378/chest.14-1687
    1. Hellyer TP, Morris AC, McAuley DF, Walsh TS, Anderson NH, Singh S, et al. Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia. Thorax. 2015;70(1):41–7. 10.1136/thoraxjnl-2014-205766
    1. de Brito RC, Lucena-Silva N, Torres LC, Luna CF, Correia JB, da Silva GA. The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia. BMC Pulm Med. 2016;16(1):170 10.1186/s12890-016-0324-z
    1. LaPar DJ, Rosenberger LH, Walters DM, Hedrick TL, Swenson BR, Young JS, et al. Severe traumatic head injury affects systemic cytokine expression. J Am Coll Surg. 2012;214(4):478–86; discussion 86–8. 10.1016/j.jamcollsurg.2011.12.015
    1. Millo JL, Schultz MJ, Williams C, Weverling GJ, Ringrose T, Mackinlay CI, et al. Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia. Intensive Care Med. 2004;30(1):68–74. 10.1007/s00134-003-2060-0 .
    1. Minei JP, Nathens AB, West M, Harbrecht BG, Moore EE, Shapiro MB, et al. Inflammation and the Host Reponse to Injury, a Large-Scale Collaborative Project: Patient-Oriented Research Core—Standard Operating Procedures for Clinical Care: II. Guidelines for Prevention, Diagnosis and Treatment of Ventilator-Associated Pneumonia (VAP) in the Trauma Patient. Journal of Trauma and Acute Care Surgery. 2006;60(5):1106–13. 10.1097/01.ta.0000220424.34835.f1
    1. Nair GB, Niederman MS. Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med. 2015;41(1):34–48. 10.1007/s00134-014-3564-5 .
    1. Smith AD, Zhang Y, Barber RC, Minshall CT, Huebinger RM, Allen MS. Common Lung Microbiome Identified among Mechanically Ventilated Surgical Patients. PLoS One. 2016;11(11):e0166313 10.1371/journal.pone.0166313
    1. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(Suppl 1):4516–22. 10.1073/pnas.1000080107
    1. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–41. 10.1128/AEM.01541-09
    1. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27(16):2194–200. 10.1093/bioinformatics/btr381
    1. Wang Y, Qian PY. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One. 2009;4(10):e7401 10.1371/journal.pone.0007401
    1. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71(12):8228–35. 10.1128/AEM.71.12.8228-8235.2005
    1. van der Maaten L, Hinton G. Visualizing Data using t-SNE. J Mach Learn Res. 2008;9:2579–605.
    1. Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis. 2013;26(2):140–50.
    1. Zosa BM, Golob JF, Conrad-Schnetz KJ, Schechtman D, Kreiner LA, Claridge JA. Current Pneumonia Surveillance Methodology: Similar Underestimation in Trauma and Surgical Patients in the Intensive Care Unit. Surg Infect (Larchmt). 2017;18(5):558–62. 10.1089/sur.2016.152 .
    1. O’Horo JC, Kashyap R, Sevilla Berrios R, Herasevich V, Sampathkumar P. Differentiating infectious and noninfectious ventilator-associated complications: A new challenge. Am J Infect Control. 2016;44(6):661–5. 10.1016/j.ajic.2015.12.032
    1. Scholte JB, van der Velde JI, Linssen CF, van Dessel HA, Bergmans DC, Savelkoul PH, et al. Ventilator-associated Pneumonia caused by commensal oropharyngeal Flora; [corrected] a retrospective Analysis of a prospectively collected Database. BMC Pulm Med. 2015;15:86 10.1186/s12890-015-0087-y
    1. Scholte JB, van Dessel HA, Linssen CF, Bergmans DC, Savelkoul PH, Roekaerts PM, et al. Endotracheal aspirate and bronchoalveolar lavage fluid analysis: interchangeable diagnostic modalities in suspected ventilator-associated pneumonia? J Clin Microbiol. 2014;52(10):3597–604. 10.1128/JCM.01494-14
    1. Fujitani S, Cohen-Melamed MH, Tuttle RP, Delgado E, Taira Y, Darby JM. Comparison of semi-quantitative endotracheal aspirates to quantitative non-bronchoscopic bronchoalveolar lavage in diagnosing ventilator-associated pneumonia. Respir Care. 2009;54(11):1453–61. .
    1. Sauaia A, Moore FA, Moore EE, Haenel JB, Kaneer L, Read RA. Diagnosing pneumonia in mechanically ventilated trauma patients: endotracheal aspirate versus bronchoalveolar lavage. J Trauma. 1993;35(4):512–7. .
    1. Wu CL, Yang D, Wang NY, Kuo HT, Chen PZ. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest. 2002;122(2):662–8. .
    1. Conway Morris A, Kefala K, Wilkinson TS, Moncayo-Nieto OL, Dhaliwal K, Farrell L, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax. 2010;65(3):201–7. 10.1136/thx.2009.122291
    1. Grover V, Pantelidis P, Soni N, Takata M, Shah PL, Wells AU, et al. A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study. PLoS One. 2014;9(10):e109686 10.1371/journal.pone.0109686

Source: PubMed

3
Abonnieren